Transparency of cooperation
Each year we publish a report covering our cooperation with healthcare professionals and healthcare organisations, including the fees and other financial benefits that they have received.
Disclosure is carried out in accordance with the instructions of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and its member organisation Pharma Industry Finland. For its part, Biocodex Nordics wants to ensure transparency and openness of the cooperation. Cooperation between healthcare professionals and pharmaceuticals industry is essential for developing the healthcare sector, creating pharmaceutical innovations and ensuring drug safety. Healthcare professionals are given the latest information about pharmaceutical treatments, and they, in turn, can serve as expert advisers to pharmaceutical companies. We cooperate for the benefit of patients. The information about cooperation between pharmaceutical companies and healthcare professionals is available to everyone.
Download the attached files for details:
Want to know more?
Biocodex operates in more than 120 countries where we anchor our operations through robust partnerships and by creating our own operational footprint through 20 subsidiaries around the world. Biocodex’s 1,530 employees are committed to serving millions of patients around the world. We apply our expertise to a wide range of products to meet patient needs, focusing on three pillars: the Microbiota Mission, orphan drugs and women’s health.